National Eye Institute: Study Confirms Long-Term Benefit of Implant for Blinding Eye Disease
August 09, 2025
August 09, 2025
BETHESDA, Maryland, Aug. 9 (TNSjou) -- The National Eye Institute issued the following news:
* * *
Study confirms long-term benefit of implant for blinding eye disease
Phase 3 trial results helped support FDA approval of ENCELTO, the first cell-based therapy for a neurodegenerative retinal condition called MacTel
*
For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vis . . .
* * *
Study confirms long-term benefit of implant for blinding eye disease
Phase 3 trial results helped support FDA approval of ENCELTO, the first cell-based therapy for a neurodegenerative retinal condition called MacTel
*
For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vis . . .